Dawn Of A New Era? Korean Biopharma M&A Landscape Set For Change
Cash-Rich Pharmas, Conglomerates Hunt For Growth Engines
Executive Summary
Mergers and acquisitions are set to gain momentum in South Korea as firms outside the sector seek new growth engines and more open-minded biopharma companies seek rapid growth and globalization.